Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma 8 Liposarcoma 8 Hemangiosarcoma 8 Fibrosarcoma 8 Lymphoma, Large B-Cell, Diffuse 7 Sarcoma, Synovial 6 Rhabdomyosarcoma 6 Neurofibrosarcoma 6 Malignant mesenchymal tumor 6 Leukemia 6 Leiomyosarcoma 6 Histiocytoma, Malignant Fibrous 6 Hemangiopericytoma, Malignant 6 Testicular Neoplasms 5 Teratoma 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Testicular Germ Cell Tumor 4 Ovarian Neoplasms 4 Lymphoma, Non-Hodgkin 4 Endodermal Sinus Tumor 4 Seminoma 3 Neuroblastoma 3 Neoplasm Metastasis 3 Lymphoma, Follicular 3 Hodgkin Disease 3 Carcinoma, Embryonal 3

Interventions

Vaccines, Synthetic 1 Paclitaxel 1 Ifosfamide 1 Fentanyl 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Penile Neoplasms × Ifosfamide × Clear all

NCT02305654 2025-04-02

InPACT

Institute of Cancer Research, United Kingdom

Phase 3 Recruiting

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡